Drugs / Pneumococcal polysaccharide conjugate vaccine, 10 valent adsorbed.
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01339923 | Apr 2011 → Jan 2014 | meningococcal meningitis | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pneumococcal polysaccharide conjugate vaccine, 10 valent adsorbed. | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01339923 ↗ |
| Known as | PHiD-CV | “Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B...” PMID 31327652 ↗ Jul 2019 |
| Modality | Vaccine | “pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)” PMID 31327652 ↗ Jul 2019 |